A timing signal, not a sedative

Melatonin

Melatonin is a hormone produced by the pineal gland that signals darkness to the body and sets circadian phase. As a supplement it is most effective for circadian disruptions — jet lag, shift work, delayed sleep phase — not as a sedative for general insomnia. Most people take far too much of it.

Bottom line

Melatonin is the clearest tool for circadian rhythm disruption. For general sleep difficulty it is more modest. The ideal dose is far lower than what most products contain — 0.5 mg often works as well as 5 mg with fewer side effects.

Verdict
Moderate
Best-supported use
Jet lag and circadian shift; reducing sleep onset time
Typical dose
0.5–1 mg, taken 30–60 min before target sleep time (not 5–10 mg as commonly sold)
Main upside
Strong evidence for circadian phase-shifting; the clearest supplement signal for jet lag
Main downside
Most OTC doses are 5–20x higher than effective doses; long-term nightly safety data are limited and product labels can be unreliable
Caution
Children except under paediatric guidance; people on anticoagulants, immunosuppressants or diabetes medication; pregnancy without medical advice
What it may help with

Four buckets, no mystery.

Likely helpful
  • Jet lag recovery (especially eastward travel)
  • Shifting sleep timing in delayed sleep phase disorder
  • Sleep onset in shift workers adjusting schedules
Possibly helpful
  • Reducing sleep onset time in general insomnia
  • Sleep quality in older adults (who produce less melatonin naturally)
  • Pre-surgery anxiety (studied in surgical contexts)
Unclear / mixed
  • Deep sleep quality or sleep architecture beyond onset
  • Long-term insomnia treatment
  • Broad antioxidant or longevity benefits in healthy adults
Probably overclaimed
  • Equivalent efficacy to prescription sleep aids for clinical insomnia
  • Sedative comparable to benzodiazepines
  • Safe in large doses simply because it is 'natural'
Evidence scoreboard

Every claimed effect, graded.

Each row grades the claimed effect by strength of human evidence, not mechanism or marketing.

Jet lag (phase shift and symptom reduction)
Likely helpful
Strong
Consistently one of the strongest single-compound findings in sleep research. Cochrane review supports efficacy.
Sleep onset latency (circadian disruption)
Likely helpful
Moderate
Reliable effect in shift work, DSPS, and jet lag contexts.
Sleep onset in general insomnia
Possibly helpful
Moderate–low
Modest reduction in sleep onset time; smaller effect than in circadian disruption contexts.
Sleep quality in older adults
Possibly helpful
Moderate–low
Older adults produce less melatonin; supplementation shows modest improvements in quality and duration.
Total sleep time or deep sleep in healthy young adults
Unclear / mixed
Insufficient
Little evidence that melatonin improves sleep depth or duration in people without circadian disruption.
Antioxidant / longevity outcomes
Probably overclaimed
Early / speculative
High melatonin concentrations have antioxidant properties in vitro; clinical relevance at supplement doses is unclear.
Consensus snapshot

What the science currently says.

Mainstream

Effective for circadian phase disruption. A reasonable short-term option for jet lag and shift work. Not a first-line treatment for chronic insomnia.

Enthusiasts claim

Often used nightly in high doses as a general sleep supplement; sometimes promoted for anti-aging and immune support.

Where the gap is

The dose gap is the most important misunderstanding. Standard OTC doses (3–10 mg) are pharmacological, not physiological. Most research showing benefit used 0.5–1 mg. Higher doses may produce next-day grogginess, and long-term nightly safety data remain limited.

  • Melatonin is a phase-shifting signal, not a sleep drug — it tells the body when to sleep, not how to sleep.

  • The most robust evidence is for jet lag, particularly eastward travel, where 0.5–5 mg taken at destination bedtime shortens adaptation.

  • Effective dose is much lower than common product doses — 0.5 mg is often indistinguishable from 3 mg in RCTs.

  • Long-term nightly use has not been shown to damage natural melatonin production in short studies, but long-term data are limited.

  • US supplement products may contain substantially more or less melatonin than the label states; quality control matters.

  • Timing matters more than dose — taking melatonin at the wrong phase can actually delay sleep.

Mechanisms

Why it might work.

Mechanism is not outcome. Each mechanism is labelled by how far it has been validated in humans.

Supported in humans

MT1/MT2 receptor activation

Melatonin acts on MT1 and MT2 receptors in the suprachiasmatic nucleus (the brain's master clock), signalling darkness and suppressing wake-promoting activity.

Supported in humans

Circadian phase shifting

Taken at the right time relative to current circadian phase, melatonin can advance or delay the body clock — the core mechanism for jet lag treatment.

Plausible

Core body temperature reduction

Melatonin promotes peripheral vasodilation and modest core temperature reduction, facilitating the thermal conditions for sleep onset.

Mostly mechanistic

Antioxidant activity

Melatonin is a potent free radical scavenger in cell studies. Whether supplemental doses confer meaningful antioxidant protection in humans is unclear.

Dosage & timing

How it is used in studies.

Typical studied dose
0.5–1 mg is often sufficient; rarely need more than 3 mg
Timing
30–60 minutes before target sleep time. For jet lag, at destination bedtime (not home bedtime)
With or without food
Food may slightly delay absorption; take on an empty stomach or light snack for fastest onset
Duration used in studies
Short-term use is well-studied. Most jet lag protocols last 3–5 days. Long-term nightly use data are sparse
Upper caution
Standard OTC doses of 5–10 mg are far above physiological levels. Higher doses do not increase benefit and increase next-day grogginess
Beyond sleep
For DSPS (night-owl schedule): low dose (0.5 mg) taken 5–6 hours before current natural sleep time gradually advances the clock. For shift work: timing is complex — consider consulting a sleep specialist.
Safety

Side effects and interactions.

General

Short-term use at low doses is well-tolerated in healthy adults. Long-term nightly use is less studied. Unlike most sleep medications, no dependence or withdrawal syndrome has been documented.

Possible side effects
  • Next-day drowsiness or grogginess, especially at higher doses
  • Headache in some users
  • Vivid dreams
  • Mild dizziness
Interactions to watch
  • Anticoagulants (warfarin) — melatonin may increase bleeding risk
  • Immunosuppressants — melatonin modulates immune function
  • Diabetes medications — may affect blood sugar; monitor levels
  • Sedatives and CNS depressants — additive sedation

This page is educational and not medical advice. Melatonin is a hormone. Use in children, pregnant women and people on medications should be discussed with a clinician.

Best use cases

Who it is actually for.

  • Travellers crossing multiple time zones (especially eastward)
  • Shift workers needing to shift sleep timing
  • Older adults with reduced natural melatonin production and mild sleep complaints
  • People with delayed sleep phase who want to move their bedtime earlier
Not worth it if...

When to skip it.

  • You already sleep well and want to sleep 'better' — melatonin is not a sleep enhancer for normal sleepers
  • You have chronic insomnia not related to circadian disruption — address sleep hygiene and CBT-I first
  • You are taking it at random times hoping for sedation
  • You are using high-dose products (5–10 mg) thinking more is better
Key references

A compact study stack.

A small, curated set — not a literature dump. Each reference comes with a single-line takeaway.

  1. 01
    Melatonin for the prevention and treatment of jet lag
    Herxheimer A, Petrie KJ. · Cochrane Database of Systematic Reviews · 2002

    Melatonin is effective for preventing or reducing jet lag. Doses of 0.5–5 mg are similarly effective; higher doses may cause more side effects.

    meta analysis
  2. 02
    Meta-analysis: melatonin for the treatment of primary sleep disorders
    Ferracioli-Oda E et al. · PLOS ONE · 2013

    Melatonin reduced sleep onset latency and increased total sleep time in primary sleep disorders, though effect sizes were modest.

    meta analysis
  3. 03
    Low doses of melatonin and sleep deprivation in healthy adults
    Cajochen C et al. · Sleep · 2003

    0.3 mg melatonin increased sleepiness and lowered core body temperature at the correct circadian time — confirming low-dose efficacy.

    rct